Galectin Therapeutics (GALT) Tops Q2 EPS by 4c

August 9, 2016 7:52 AM EDT
Get Alerts GALT Hot Sheet
Trade GALT Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Galectin Therapeutics (NASDAQ: GALT) reported Q2 EPS of ($0.20), $0.04 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Galectin Therapeutics (GALT) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment